Pfizer (PFE)

EBITDA Growth

-40.76%

TTM · Period ending:

PFE logo

PFE EBITDA Growth

Year-over-year change vs the same period a year earlier

Latest reported-40.76%
PFE TTM EBITDA YoY % (7.45% → -40.76%)
High-resolution chart · PNG

PFE ebitda growth history

Trailing twelve months (TTM). Each value covers four complete reported quarters.

Pfizer EBITDA Growth — Trailing twelve months (TTM)
Period endingEBITDA Growth
41.1081%
32.9544%
44.8948%
41.7958%
45.272%
75.447%
59.6982%
40.2315%
33.4168%
15.4885%
8.4169%
12.9704%
7.1046%
5.4145%
9.8869%
13.2503%
18.4766%
15.7599%
17.6451%
21.132%
24.159%
30.4066%
29.5149%
94.5857%
89.6701%
59.4023%
61.4205%
-33.2493%
-35.1208%
-16.475%
-17.8645%
30.9565%
31.3572%
15.8726%
13.972%
11.1742%
12.4677%
13.8533%
17.0495%
165.7622%
222.0191%
1,379.6402%
32.1834%
-287.3742%
-202.3733%
-109.1802%
-4.3186%
-10.7507%
-9.1013%
2.788%
7.5574%
1.7193%
6.2262%
6.8659%
-1.9694%
5.2752%
7.4521%
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.